Showing results (251-260 of 665) with videos related to
Sort By:
Pageof 67
Free Radical Biology & Medicine|June 17, 1998
Superoxide dismutase in patients with chronic hepatitis C virus infectionE Larrea, O Beloqui, M A Muñoz-Navas, et al.Chemotherapy|September 1, 1996
Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitroF Fuentes, M M Martín, J Izquierdo, et al.Journal of Hepatology|November 1, 1993
Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferonJ Camps, N García, J I Riezu-Boj, et al.The Canadian Journal of Cardiology|April 29, 2000
Factors predictive of oxygen consumption during the immediate postoperative period in open heart surgeryR Cartier, J Prieto, Y Leclerc, et al.The Journal of Hand Surgery|August 14, 1999
Upper extremity infections in patients with diabetes mellitusM H Gonzalez, S Bochar, J Novotny, et al.Journal of Chemotherapy (Florence, Italy)|January 12, 2001
In vitro activity of clarithromycin against penicillin-susceptible and penicillin-resistant strains of Streptococcus pneumoniae in a pharmacodynamic simulation modelF Fuentes, D Sevillano, I P Balcabao, et al.Scandinavian Journal of Infectious Diseases|January 1, 1996
Postantifungal effect and effects of low concentrations of amphotericin B and fluconazole on previously treated Candida albicansF Mínguez, M T García, J E Lima, et al.Neurologia (Barcelona, Spain)|February 1, 2014
Transcultural adaptation and validation of the Spanish version of EUROQUESTD Marhuenda, M J Prieto, A Cardona, et al.Antimicrobial Agents and Chemotherapy|April 4, 1998
Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coliF Fuentes, J Izquierdo, M M Martín, et al.Chemotherapy|January 1, 1995
Enhancement of the susceptibility of Staphylococcus aureus to phagocytosis after treatment with fosfomycin compared with other antimicrobial agentsP Pérez Fernández, I Herrera, P Martínez, et al.Pageof 67